C. Croot

Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy.

M. Fesen, Denise Williams, R. Waltzman, 2005, The oncologist.

Final hematologic results: Epoetin alfa (EPO) 40,000 U QW vs darbepoetin alfa (DARB) 200 μg Q2W in anemic cancer patients (pts) receiving chemotherapy (CT)

Denise Williams, R. Waltzman, C. Croot, 2005 .

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.

A. Dobs, J. Dalton, M. Steiner, 2013, The Lancet. Oncology.

Epoetin alfa 40,000 U QW vs darbepoetin alfa 200 mcg Q2W in anemic cancer patients receiving chemotherapy: Preliminary results of a comparative trial.

M. Fesen, R. Waltzman, G. Justice, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ymptom anagement and upportive Randomized Comparison of Epoetin Alfa (40,000 U Weekly) and Darbepoetin Alfa (200 μ g Every 2 Weeks) in Anemic Patients with Cancer Receiving Chemotherapy

M. Fesen, R. Waltzman, V. Charu, 2005 .